More recent studies, also found that semaglutide reduced visceral adiposity and associated epicardial inflammation on imaging study, suggesting that GLP-1RAs may address both skin and fat-related inflammation in PsO patients with obesity and T2DM (58)
I didnt even realize it was connected until I ran out- after a week of not taking it, they were back
The management of patients include patient-reported outcomes for long-term follow-up care and for early detection of possible adverse events and the use of digital technologies, such as telemedicine - videoconferences for patients follow-up and reinfection risk elimination, digital therapeutics approach, especially for non-pharmaceutical interventions (e.g., breathing exercises), electronic control of body parameters such as temperature, oxygen saturation, blood pressure, that can be measured with wearable devices and the data can be analyzed with artificial intelligence (256, 257)
2021 May 28;6(1):188
Those with objective evidence of disease control (normal fecal calprotectin, endoscopic remission) may be better candidates than those with frequent flares or active inflammation
The science looks solid
:max_bytes(150000):strip_icc()/WouldYouBeMoreLikelytoTakeGLP-1sifTheyCameinPill-Form_final-2741a721ac7748639cf0256d61df3b7f.png)
